BPC-157

Also known as: Body Protection Compound-157

Overview

BPC-157 is a synthetic peptide that accelerates healing, reduces inflammation, and supports tissue repair across muscles, tendons, and the gut. It also promotes gut health, protects the stomach lining, and aids recovery in injuries and neurological conditions. BPC-157 is a 15-amino acid synthetic peptide derived from a protein found in the gastric juice of humans. Known for its broad-spectrum healing properties, it promotes tissue repair, modulates angiogenesis, and supports gut-brain axis health. This peptide accelerates wound healing, reduces inflammation, and fosters cellular regeneration across multiple systems, including musculoskeletal, gastrointestinal, and neurological tissues.

Benefits

- Accelerates tissue repair

- Promotes angiogenesis

- Treats gut conditions

- Supports neurological recovery

- Improves neurotransmitter production

- Reduces oxidative stress

- Mitigates inflammation

- Increases growth hormone receptors

Consider This Peptide If You Want To

- Accelerate healing and tissue repair for injuries related to muscles, tendons, ligaments, or the gastrointestinal tract

- Reduce inflammation and protect against gut damage (e.g., ulcers, leaky gut, IBD)

Dosage & Administration

Dosage Guidelines

Recommended Dosage

• Amount: 250 mcg

• Frequency: daily

• Duration: 8 weeks

• Rest Period: 8 weeks

• Time of Day: morning

• Ingestion: subcutaneous

Administration Routes:

- Subcutaneous

- Intramuscular

- Oral

Oral Administration:

• Standard Dosage: 500-1000 mcg daily

• Timing: Daily

• Duration: 4-8 week cycle, 4-8 weeks off

Research Findings on Dosage:

1. Subcutaneous or Intramuscular Injection:

• Commonly Reported Dosage: 250-500 mcg daily

• Duration: 4-8 week cycle, 4-8 weeks off

i. Injury specific: split dose into two injections per day and inject in a site-specific manner around injury

2. Oral Administration:

• Commonly Reported Dosage: 500-1000 mcg daily

Mechanism of Action

How this peptide works in the body

Angiogenesis Modulation:

• BPC-157 upregulates vascular endothelial growth factor (VEGF) and its receptor VEGFR2, stimulating angiogenesis (new blood vessel formation) and increasing oxygen and nutrient delivery to damaged tissues. It also enhances endothelial nitric oxide synthase (eNOS) activity, boosting nitric oxide (NO) production, which improves vasodilation and microcirculation for better tissue perfusion and healing.

Inflammation Reduction:

• BPC-157 suppresses pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, reducing inflammatory damage and oxidative stress. It also upregulates IL-10, an anti-inflammatory cytokine, while inhibiting NF-κB activation, preventing excessive inflammatory signaling and oxidative damage. Additionally, it modulates COX-1 and COX-2 activity, balancing prostaglandin production to reduce pain and inflammation while supporting gastrointestinal mucosal protection.

Tissue Regeneration:

• BPC-157 stimulates fibroblast growth factor (FGF) pathways, enhancing fibroblast migration and proliferation for faster wound healing. It also upregulates TGF-β/Smad signaling, increasing collagen type I and III synthesis, which is crucial for connective tissue repair. By modulating integrins and laminins, it strengthens extracellular matrix (ECM) stability, ensuring proper tissue remodeling. Additionally, it increases growth hormone receptor (GHR) expression, enhancing GH-mediated repair processes.

Neuroprotection:

• BPC-157 regulates serotonergic (5-HT), dopaminergic (D1/D2), and GABAergic neurotransmitter systems, stabilizing mood, cognition, and neuroplasticity. It reduces neuroinflammation by suppressing microglial activation and cytokine release, protecting against CNS degeneration. By upregulating nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), it supports neuronal survival and synaptic plasticity, aiding nerve regeneration and repair. Additionally, it enhances Schwann cell proliferation, facilitating myelination and peripheral nerve healing.

Gut-Brain Axis Regulation:

• BPC-157 strengthens intestinal barrier function by upregulating zonula occludens-1 (ZO-1) and occludin, improving tight junction integrity and reducing gut permeability ("leaky gut"). It activates epidermal growth factor (EGF) pathways, promoting epithelial regeneration and gut lining repair. By lowering lipopolysaccharide (LPS)-induced endotoxemia, it reduces systemic inflammation and neuroimmune dysfunction. Additionally, it modulates enteric neurotransmitters (serotonin, dopamine, acetylcholine), improving gut motility and reducing symptoms of gastrointestinal disorders.

Consider Stacking With

- Any GHRP (Ipamorelin, Hexarelin)

- Any GHRH (CJC-1295, MOD-GRF-129, Tesamorelin)

- TB-4

- Kisspeptin-10

- 5-Amino-1MQ

- KPV/VIP/LL-37

- IGF-1 LR3

- Semax/Selank/Cerebrolysin

Side Effects & Cautions

Common Side Effects

- Mild redness or swelling at the injection site

- Nausea

- Headaches

Cautions

- Avoid use in conditions where angiogenesis suppression is necessary (e.g., active cancers)

Rare Side Effects

- Potential for mast cell activation or histamine response

Research & References

Research Highlights

1. Gastric Protection and Healing in Ulcers (2021): Demonstrated accelerated mucosal healing in animal models of NSAID-induced gastric damage.

2. Musculoskeletal Soft Tissue Healing (2019): Showed faster recovery in tendon, ligament, and skeletal muscle injuries.

3. Neuroprotection in Brain Trauma (2010): Reduced brain edema, improved consciousness, and decreased mortality in TBI animal models.

4. Gut-Brain Axis Study (2016): Highlighted its role in reducing intestinal inflammation and promoting neural recovery.

References

• Chang, J.K. et al., "Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts," International Journal of Molecular Sciences, 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6271067/

• Sikiric, P. et al., "Pentadecapeptide BPC 157 and the Central Nervous System," Current Neuropharmacology, 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8504390/

• Seiwerth, S. et al., "Stable Gastric Pentadecapeptide BPC 157 and Wound Healing," Frontiers in Pharmacology, 2021. https://www.frontiersin.org/articles/10.3389/fphar.2021.627533/full

• Chang, J.K. et al., "The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing Involves Tendon Outgrowth, Cell Survival, and Cell Migration," Journal of Applied Physiology, 2011. https://journals.physiology.org/doi/full/10.1152/japplphysiol.00945.2010

• Pevec, D. et al., "Stable Gastric Pentadecapeptide BPC 157 Can Improve the Healing of Segmental Bone Defect," Journal of Orthopaedic Surgery and Research, 2019. https://josr-online.biomedcentral.com/articles/10.1186/s13018-019-1242-6